Biotech ends summer on a high

Biotech finished on a high in August, according to San Francisco venture capital firm Burrill & Company.

The company’s Burrill Biotech Select Index closed up 4.4 percent on Friday before the Labor Day holiday weekend, said G. Steven Burrill, company CEO.

Top performers included Emeryville’s Onyx Pharmaceuticals (ONXX), up 42 percent, and Vertex Pharmaceuticals, up 21 percent.

businessBusiness & Real Estate

If you find our journalism valuable and relevant, please consider joining our Examiner membership program.
Find out more at www.sfexaminer.com/join/
Previous story
Oracle to acquire Ireland's Netsure
Next story
Business briefs: 'Second Life' crisis

Just Posted

SFUSD: City schools to stay closed for the rest of the year

District joins five other Bay Area districts in announcing closure

John Prine, revered singer-songwriter, dies of COVID-19 complications at 73

John Prine, who traded his job as a Chicago mail carrier to… Continue reading

Supes push to procure hotel rooms for the homeless as coronavirus spreads

‘Friction’ between board and mayor over strategy to protect those living on the streets

Coronavirus cases exceed 600 in SF; 9 reported dead

Mayor launches data tracker after calls for transparency

Breed changes plans for massive new Moscone West homeless shelter

City now moving more shelter residents to hotel rooms after three test positive for COVID-19

Most Read